Several Israeli companies and academies are working to develop domestic COVID-19 vaccines to protect against variants of the virus.
Read more here.
More from OurCrowd Blog
[OncoHost in PR Newswire] OncoHost announces interim results from PROPHETIC trial, multicenter assessment of NSCLC patient response to immunotherapy
Source Node: 1587657
Time Stamp: Jan 12, 2022
[BlueNalu in Triple PunDit] Lab-Grown Fish: The Next Revolution in Sustainable Seafood?
Source Node: 1149240
Time Stamp: Sep 30, 2021
[Insightec in WRAL News] Noninvasive ultrasound technology offering new hope for Parkinson’s, essential tremor patients – OurCrowd Blog
Source Node: 2530767
Time Stamp: Mar 26, 2024
[Hailo in Calcalist] New unicorn Hailo raises $136 million Series C for AI chips for edge devices
Source Node: 1136761
Time Stamp: Oct 11, 2021
[Nexa3D in Business Wire] Nexa3D SLS system decouples 3D printing and cooling processes to maximize productivity
Source Node: 1564778
Time Stamp: Nov 17, 2021
[Virgin Hyperloop One in Fast Company] The best mobility design of 2021
Source Node: 1170198
Time Stamp: Sep 21, 2021
[Memic in MD+DI] First-of-a-kind surgical robot headed to gynecologic surgery meeting
Source Node: 1523995
Time Stamp: Nov 11, 2021
[ICON in axios] 3D-printed home community comes to Austin
Source Node: 1303411
Time Stamp: Oct 27, 2021
[yulife in COVER] Financial wellbeing worries surge among two thirds of UK working adults
Source Node: 1906888
Time Stamp: Jan 18, 2023
[Classiq in Digital Journal] Software will become the final key to unlocking quantum computing power
Source Node: 1438118
Time Stamp: Nov 3, 2021
[CyberMDX in Globes] Forescout buys Israeli medical security co CyberMDX
Source Node: 1599705
Time Stamp: Feb 1, 2022